Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...
Noom is a personalized health and wellness app that provides access to coaching in your pocket. The company’s habit-changing solutions include daily lessons and progress tracking for weight loss and ...
Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US. The bold move has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results